Koschalk, Arianna

Child Development Center and Child Therapists Near You PediaPlex is an autism spectrum disorder-specialty practice led by Sonia Kirkpatrick, MBA, and her expert team, with locations in Southlake, Alliance, Fort Worth, and Frisco, Texas. Ms. Kirkpatrick was inspired to open the practice after her daughter was diagnosed with autism. PediaPlex is a collaborative center that encompasses all therapies to reduce the severity of autism spectrum disorder symptoms and help children thrive better at school, at home, and in interpersonal relationships. The practice offers applied behavior analysis (ABA) therapy, CentralReach ABA software, speech therapy, occupational therapy, feeding therapy, and more—all in one location. Providers at PediaPlex are registered behavioral therapists and highly trained in their fields. They maintain their expert credentials with continuing education, to stay current in the latest advances in autism spectrum disorder therapies and other treatments. The experienced team personalizes treatments for children based on their individualized needs and goals, because autism affects each child differently. After receiving an autism diagnosis, children at PediaPlex begin treatment to improve behaviors, social skills, and communication with friendly, compassionate therapists. To learn more about the many autism spectrum disorder treatments available at PediaPlex, schedule an evaluation for your child by phone today. Start your child's journey today.

Caris Life Sciences® is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve cancer patient outcomes. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence and machine learning algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing needed to analyze and unravel the molecular complexity of disease. With a primary focus on cancer, Caris' suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers better detect, diagnose and treat patients. Caris' latest advancement is a blood-based, cNAS assay that combines comprehensive molecular analysis and serial monitoring - making it the most powerful liquid biopsy assay ever developed.